Luchan Deng

1.7k total citations
8 papers, 212 citations indexed

About

Luchan Deng is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Luchan Deng has authored 8 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Luchan Deng's work include MicroRNA in disease regulation (3 papers), Mesenchymal stem cell research (2 papers) and Circular RNAs in diseases (2 papers). Luchan Deng is often cited by papers focused on MicroRNA in disease regulation (3 papers), Mesenchymal stem cell research (2 papers) and Circular RNAs in diseases (2 papers). Luchan Deng collaborates with scholars based in China, United Kingdom and Belgium. Luchan Deng's co-authors include Linyuan Fan, Haoying Xu, Junfen Fan, Yanlei Yang, Hongling Li, Robert Chunhua Zhao, Xisheng Weng, Robert Chunhua Zhao, Jing Li and Shihua Wang and has published in prestigious journals such as Cancer Research, Cell Death and Disease and Stem Cell Research & Therapy.

In The Last Decade

Luchan Deng

7 papers receiving 212 citations

Peers

Luchan Deng

MB

CR

GENET

PHYSI

SURGE

Sara García-Duque Spain

Samuel Milanovich United States

Serena Tommasini-Ghelfi United States

Federica Cappellesso Belgium

Cui‐Fen Hu China

Eleonora Isaia Italy

Xuanping Huang China

Liangji Li United States

Cornelia Stoll Germany

Rana Yadak Netherlands

Sara García-Duque Spain

Luchan Deng

192 ×1.4

MB

149 ×1.2

CR

43 ×0.8

GENET

16 ×0.5

PHYSI

27 ×1.0

SURGE

Citations per year, relative to Luchan Deng Luchan Deng (= 1×) peers Sara García-Duque

Countries citing papers authored by Luchan Deng

Since Specialization

Citations

This map shows the geographic impact of Luchan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luchan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luchan Deng more than expected).

Fields of papers citing papers by Luchan Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luchan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luchan Deng. The network helps show where Luchan Deng may publish in the future.

Co-authorship network of co-authors of Luchan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Luchan Deng. A scholar is included among the top collaborators of Luchan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luchan Deng. Luchan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Li, Jing, et al.. (2025). Abstract LB439: HP568, a highly potent and orally bioavailable ER PROTAC for breast cancer treatment, currently undergoing phase 1/2 clinical studies. Cancer Research. 85(8_Supplement_2). LB439–LB439.

2.

Wang, Ju, Pangke Yan, Chen Zhang, et al.. (2023). Abstract LB262: HSK38008: An oral AR-V7 degrader for metastatic castration-resistant prostate cancer. Cancer Research. 83(8_Supplement). LB262–LB262. 2 indexed citations

3.

Yang, Yanlei, Junfen Fan, Haoying Xu, et al.. (2021). Long noncoding RNA LYPLAL1-AS1 regulates adipogenic differentiation of human mesenchymal stem cells by targeting desmoplakin and inhibiting the Wnt/β-catenin pathway. Cell Death Discovery. 7(1). 105–105. 11 indexed citations

4.

Xu, Haoying, Yanlei Yang, Linyuan Fan, et al.. (2021). Lnc13728 facilitates human mesenchymal stem cell adipogenic differentiation via positive regulation of ZBED3 and downregulation of the WNT/β-catenin pathway. Stem Cell Research & Therapy. 12(1). 176–176. 18 indexed citations

5.

Deng, Luchan, Hongling Li, Xiaodong Su, et al.. (2020). Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell Death and Disease. 11(3). 158–158. 21 indexed citations

6.

Fan, Linyuan, Junfen Fan, Yan Liu, et al.. (2018). miR-450b Promotes Osteogenic Differentiation In Vitro and Enhances Bone Formation In Vivo by Targeting BMP3. Stem Cells and Development. 27(9). 600–611. 36 indexed citations

7.

Fan, Junfen, Yanlei Yang, Haoying Xu, et al.. (2018). MiR-1292 Targets FZD4 to Regulate Senescence and Osteogenic Differentiation of Stem Cells in TE/SJ/Mesenchymal Tissue System via the Wnt/β-catenin Pathway. Aging and Disease. 9(6). 1103–1103. 52 indexed citations

8.

Li, Hongling, Junfen Fan, Linyuan Fan, et al.. (2018). MiRNA-10b Reciprocally Stimulates Osteogenesis and Inhibits Adipogenesis Partly through the TGF-β/SMAD2 Signaling Pathway. Aging and Disease. 9(6). 1058–1058. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact